On the contrary, the ability of anti-CD11a treated tumor cells to metastasize to the liver was found to be reduced by 50% in metastatic area in the liver compared to livers receiving untreated tumor cells, and by 65% when compared to metastasis generated by sICAM-1 pretreated tumor cells (Fig. 5A). The gene discussed is ITGAL; the disease is neoplasm.